QCLS
$3.67-0.27 (-6.85%)
Market ClosedAs of Mar 20, 8:00 PM UTC
Q/C Technologies, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets.
Historical Price
Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
AAPLMSFTGOOGL
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$3.67
Potential Upside
5%
Whystock Fair Value$3.85
Price
UndervaluedFair ValueOvervalued
Fundamentals
Q/C Technologies, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets. The company develops Isomyosamine, a clinical stage small molecule that regulates t...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$28.82M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.23
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-68.92%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.71
Recent News
No recent news found.